CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer.

MLA

Tang, Jianming, et al. “CDK2-Activated TRIM32 Phosphorylation and Nuclear Translocation Promotes Radioresistance in Triple-Negative Breast Cancer.” Journal of Advanced Research, vol. 61, July 2024, pp. 239–51. EBSCOhost, https://doi.org/10.1016/j.jare.2023.09.011.

APA

Tang, J., Li, J., Lian, J., Huang, Y., Zhang, Y., Lu, Y., Zhong, G., Wang, Y., Zhang, Z., Bai, X., Fang, M., Wu, L., Shen, H., Wu, J., Wang, Y., Zhang, L., & Zhang, H. (2024). CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer. Journal of Advanced Research, 61, 239–251. https://doi.org/10.1016/j.jare.2023.09.011

Chicago

Tang, Jianming, Jing Li, Jiayan Lian, Yumei Huang, Yaqing Zhang, Yanwei Lu, Guansheng Zhong, et al. 2024. “CDK2-Activated TRIM32 Phosphorylation and Nuclear Translocation Promotes Radioresistance in Triple-Negative Breast Cancer.” Journal of Advanced Research 61 (July): 239–51. doi:10.1016/j.jare.2023.09.011.